1867 (1867) Fair Value & Analysis

Industrials · Market cap HK$281M

1 1867 1867 · HK

PriceHK$0.1880

Fair ValueHK$0.0400

Upside-78.7%

Quality31/100

Watch 1867 for free — get notified when fair value or trend changes. Watch for free

Evidence: Low Range HK$0.0300 – HK$0.0600

Fair value as of: Jul 2, 2026

From 1 valuation models · updated today

Share price −12.6% over the past month.

Price vs Fair Value (12 months)

12‑month range HK$0.1350 – HK$0.2950 · fair‑value band HK$0.0300 – HK$0.0600 · the HK$0.1880 price screens above the HK$0.0400 fair value. As of Jul 2, 2026.

✦ Which stocks are undervalued right now? Check free Discover now →

Analysis

1867 (1867) currently trades at HK$0.1880, while our model-based Fair Value estimate is HK$0.0400 — implying the stock looks roughly 78.7% overvalued today. We read business quality at 31/100 (below-average quality), in the Industrials sector. Bear case: priced above our estimate, the market already discounts strong expectations. Bull case: above-average quality can justify a premium — the entry price still matters most (evidence: low).

Over the trailing twelve months, 1867 generated revenue of HK$229M at a net margin of -22.4%. Revenue declined 50.1% year over year. It earns a return on equity of -48.6%. Net debt stands at HK$149M. Fundamentals as of Jul 2, 2026

Key figures & financial health

Revenue (TTM) HK$229M

Revenue growth (YoY) -50.1%

Net margin -22.4%

Return on equity -48.6%

Free cash flow −HK$90.4M FY2024

Operating margin -24.5%

More key figures

EPS (TTM) HK$-0.0300

EPS growth (YoY) -39.3%

Net debt HK$149M FY2024

Figures from reported company fundamentals (EODHD) · as of Jul 2, 2026. TTM = trailing twelve months.

Revenue & earnings trend

FY2020 – FY2024 · reported fiscal years

1867 reported revenue of HK$301M in FY2024 versus HK$296M in FY2020, a compound +0.4%/yr. Reported net income was −HK$50.0M in FY2024.

Revenue +0.4%/yr

FY20 HK$296M

FY21 HK$307M

FY22 HK$661M

FY23 HK$490M

FY24 HK$301M

Net income

FY20 HK$1.0M

FY21 −HK$21.0M

FY22 −HK$8.8M

FY23 −HK$19.9M

FY24 −HK$50.0M

Is 1867 fairly valued? → Check now

Similar stocks

6 more Consulting Services stocks, each showing price versus our Fair Value estimate (as of Jul 2, 2026).

Stock	Price	Fair Value	vs Fair Value
Experian plc EXPGY	$33.13	$29.60	-11%
SGS SA SGSOF	$110.42	$84.42	-24%
Verisk Analytics, Inc VRSK	$183.13	$129.20	-29%
Equifax Inc EFX	$170.99	$104.33	-39%
Bureau Veritas SA BVRDF	$30.75	$31.79	+3%
Booz Allen Hamilton Holding BAH	$78.94	$96.35	+22%

Explore undervalued stocks

More undervalued Industrials stocks →

All undervalued stocks Technology Financial Services Healthcare Consumer Cyclical Consumer Defensive Communication Services Industrials Energy Basic Materials Real Estate Utilities Deeply Undervalued Stocks Undervalued Blue-Chip Stocks Undervalued Small-Cap Stocks

Frequently asked questions

Is 1867 (1867) undervalued?

As of Jul 2, 2026, our model estimates a fair value of HK$0.0400 versus a price of HK$0.1880 — about −79% (overvalued). Model-based estimate, not financial advice.

What is the fair value of 1867?

Our model-based fair value for 1867 is HK$0.0400 (as of Jul 2, 2026), built from audited fundamentals. The current price is HK$0.1880.

What is the quality score of 1867?

1867 has a Quality Score of 31/100, measuring profitability, growth and balance-sheet strength from non-valuation factors.

What is the revenue of 1867 (1867)?

1867 reported trailing-twelve-month revenue of about HK$229M (latest available figure, as of Jul 2, 2026).

What is the net profit margin of 1867?

The net profit margin of 1867 is about -22.4%, meaning it is currently running at a net loss. Based on the latest reported figures.

How we calculate Fair Value

Each company is valued through a stack of independent intrinsic-value models (DCF variants, residual-income, multiples and more), blended into one family-balanced consensus and weighted by how much trustworthy data backs it. A separate quality layer scores the fundamentals. Every input is real reported data — nothing guessed.

Educational research only · not financial advice · no buy/sell recommendation. Model-based estimates are not certainties; their reliability depends on data quality and assumptions.